CVE-2021-47858Genexis Platinum-4410 P4410-V2-1.31A contains a stored cross-site scripting vulnerability in the 'start_addr' parameter of the Security Management interface.
Updated under an hour ago ()
Does this affect you?
It lists no affected products yet. Add what you run and Signals checks it as products are added.
No exploitation reported and no EPSS estimate yet.
Genexis Platinum-4410 P4410-V2-1.31A contains a stored cross-site scripting vulnerability in the 'start_addr' parameter of the Security Management interface. Attackers can inject malicious scripts through the start source address field that will persist and trigger for privileged users when they access the security management page.
- CVSS
- 7.2 HIGH (v3.1, NVD)CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:C/C:L/I:L/A:N
- Weakness (CWE)
- CWE-79
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- Not loaded for this CVE
- Assigned by
- Not given
- NVD analysis
- Deferred
- Record last updated
- Jun 17, 2026
- First seen by InfoSec Signals
- Oct 9, 2026
Affected products
No affected products are listed yet.
References
- https://genexis.eu/product/platinum-series/
- https://www.exploit-db.com/exploits/49709
- https://www.vulncheck.com/advisories/genexis-platinum-p-a-startaddr-persistent-cross-site-scripting
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.